Back to Journals » Risk Management and Healthcare Policy » Volume 7

The exclusion of hypochromia from the iron deficiency screen

Authors Jolobe OMP

Received 28 August 2013

Accepted for publication 28 August 2013

Published 14 March 2014 Volume 2014:7 Pages 61—63

DOI https://doi.org/10.2147/RMHP.S53668

Checked for plagiarism Yes

Oscar MP Jolobe

Manchester Medical Society, Manchester, UK


When the screening strategy for iron deficiency makes use of mean corpuscular volume (MCV) to the exclusion of mean corpuscular hemoglobin (MCH), as was the case in the recent study by Radia et al1 there is a risk of repeating the mistakes highlighted in a retrospective analysis of the management of anemia, microcytosis, and hypochromia in preoperative subjects in South Australia.2


Read the original paper by Radia and colleagues.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Profile of bevacizumab and its potential in the treatment of cervical cancer

Fisher CM, Schefter TE

OncoTargets and Therapy 2015, 8:3425-3431

Published Date: 19 November 2015

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Advances in cancer pain from bone metastasis

Zhu XC, Zhang JL, Ge CT, Yu YY, Wang P, Yuan TF, Fu CY

Drug Design, Development and Therapy 2015, 9:4239-4245

Published Date: 18 August 2015

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010